August 27, 2007 NASD OTC-BB: MRDAF

Meridian Co. Proudly Announces Roberta Flack as Celebrity Spokesperson for Their Lapex 2000 Lipolaser

"The LipoLaser treatments are not only pain-free and non invasive, they are very relaxing-and most importantly, they work!" according to Ms. Flack

Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that Roberta Flack has been chosen to be their celebrity spokesperson for the LAPEX 2000 LipoLaser (BCS). This innovative medical device has recently received a CE Mark approval in the European Union and is currently pending a FDA 510 (K) clearance in the United States.

Ms. Flack has been using the LipoLaser since November, 2006 under the care and supervision of Dr. Lionel Bissoon, best selling author of The Cellulite Cure, and has lost of total of 8 inches from her abdomen.

"Like everyone else, I was interested in losing inches, but was not interested in trying invasive procedures. Even with diet and exercise those stubborn areas were difficult to reduce. Although somewhat skeptical, I was excited to try out this new laser that was designed for body contouring and fat reduction," states Ms. Flack. "The LipoLaser treatments are not only pain-free and non invasive, they are very relaxing-and most importantly, they work!"

More About: Roberta Flack

Roberta Flack is a legendary Grammy-winning singer, songwriter of ultra smooth ballads of R&B, jazz, pop, and soul. She has been described as one of the most talented pop artist of the 70s and 80s. Roberta is best known for her platinum hits "Killing Me Softly" and "First Time Ever I Saw Your Face". Ms. Flack has toured world-wide and her music continues to be played and inspires fans globally.

More About: LAPEX LipoLaser

The LAPEX 2000 LipoLaser (BCS) was designed to target the medical and aesthetic market, specifically to address body shaping/contouring and spot fat reduction. This non-invasive treatment is considered one of the most innovative methods to treat stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession, but also in any clinical setting such as medi-spas and wellness centers.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA clearance, CE Mark, Health Canada, and other international regulatory approvals. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers worldwide.

On Behalf of the Board of Directors, Hyeon Seong Myeong President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca